Acarix Investor Relations Material
Latest events
Q2 2025
Acarix
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Acarix
Access all reports
Acarix AB is a Swedish medical technology company specializing in diagnostic solutions for coronary artery disease (CAD). Its flagship product, the CADScor System, uses sensitive acoustics and advanced algorithms to assess coronary blood flow, providing a rapid, non-invasive method for ruling out CAD in patients experiencing chest pain. The system is designed for use in clinical settings by healthcare professionals to help streamline the diagnosis process. The company is headquartered in Malmö, Sweden, and its shares are traded on the Nasdaq Stockholm.
Key slides for Acarix
Latest articles
)
Verisure: Security Leader Ready for a Comeback IPO
Verisure, Europe's leading monitored alarm provider, is preparing a comeback IPO in 2025 that could be one of the year's most significant listings.
16 Sep 2025
)
Stephen J. Squeri: American Express Veteran Chairman and CEO
Stephen Squeri has spent over four decades at American Express, rising through the ranks to lead one of the world's most recognized brands.
15 Sep 2025
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
Ticker symbol
ACARIX
Country
🇸🇪 Sweden